A recent study found no significant difference in the risk of cardiovascular events among rheumatoid arthritis patients treated with Janus kinase inhibitors or biologic disease-modifying drugs.
A recent study found no significant difference in the risk of cardiovascular events among rheumatoid arthritis patients treated with Janus kinase inhibitors or biologic disease-modifying drugs.
The most experienced readers showed the highest diagnostic performance in reviewing computed tomography or magnetic resonance imaging when diagnosing axial spondyloarthritis.
The most experienced readers showed the highest diagnostic performance in reviewing computed tomography or magnetic resonance imaging when diagnosing axial spondyloarthritis.
